Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Colloids and Surfaces B: Biointerfaces

• Publication date

  2017-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.colsurfb.2017.05.032PMID 28531877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid Architectonics for Superior Oral Bioavailability of Nelfinavir Mesylate: Comparative in vitro and in vivo Assessment

  2018cited by this paper
• Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles

  2016cited by this paper
• Glucosamine and N-acetyl glucosamine as new CEST MRI agents for molecular imaging of tumors

  2016cited by this paper
• Corrigendum: Revealing the nanoparticles aspect ratio in the glass-metal nanocomposites irradiated with femtosecond laser

  2016cited by this paper
• Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.

  2016cited by this paper
• Ligand anchored poly(propyleneimine) dendrimers for brain targeting: Comparative in vitro and in vivo assessment.

  2016cited by this paper
• Relative apoptotic potential and specific G1 arrest of stigmasterol and cinnamic acid isolated from the brown algae Padina gymnospora in HeLa and A549 cells

  2016cited by this paper
• Targeting the folate receptor for the treatment of ovarian cancer

  2015cited by this paper
• Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

  2015cited by this paper
• Cancer active targeting by nanoparticles: a comprehensive review of literature

  2015cited by this paper
• Synthesis and characterization of dendro-PLGA nanoconjugate for protein stabilization.

  2015cited by this paper
• Oncogene pathway activation in mammary tumors dictates FDG-PET uptake.

  2014cited by this paper
• Synthesis of mesoporous Stöber silica nanoparticles: the effect of secondary and tertiary alkanolamines

  2014cited by this paper
• Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties.

  2013cited by this paper
• Computer-assisted coloring and illuminating based on a region-tree structure

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers

  2012cited by this paper
• Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease

  2012cited by this paper
• Synthesis, characterization and brain targeting potential of paclitaxel loaded thiamine-PPI nanoconjugates

  2012cited by this paper
• Expression of the glucose transporters GLUT1, GLUT3, GLUT4 and GLUT12 in human cancer cells

  2012cited by this paper
• Entering the Mainstream

  2010cited by this paper
• Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes.

  2009cited by this paper
• Colloidal suspensions of functionalized mesoporous silica nanoparticles.

  2008cited by this paper
• Novel PEGylated PPI Dendritic Nanostructures for Sustained Delivery of Anti-Inflammatory Agent

  2008cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Functional properties and genomics of glucose transporters.

  2007cited by this paper
• Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

  2007cited by this paper
• Cancer's molecular sweet tooth and the Warburg effect.

  2006cited by this paper
• The role of folate receptor α in cancer development, progression and treatment: Cause, consequence or innocent bystander?

  2006cited by this paper
• Differential subcellular distribution of glucose transporters GLUT1–6 and GLUT9 in human cancer: Ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues

  2006cited by this paper
• Pros and Cons of the Liposome Platform in Cancer Drug Targeting

  2006cited by this paper
• A simple technique for quantifying apoptosis in 96-well plates

  2005cited by this paper
• Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.

  2005cited by this paper
• Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer

  2005cited by this paper
• Drug Delivery Systems: Entering the Mainstream

  2004cited by this paper
• Expression of glucose transporter 5 by microglia in human gliomas

  2004cited by this paper
• Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy.

  2004cited by this paper
• Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates.

  2003cited by this paper
• Differential expression of GLUT12 in breast cancer and normal breast tissue.

  2003cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• [Origin of cancer cells].

  1956cited by this paper

• Engineering bipedal Janus nanocarriers: Dual-targeting and pH/microwave-responsive drug delivery system for cancer therapy

  2025cites this paper
• Biodegradable polyester-based hyperbranched nanocarrier-modified with N-acetyl glucosamine for efficient drug delivery to cancer cells through GLUTs

  2025cites this paper
• Recent advances in microbial production of nutraceuticals: a sustainable approach

  2025cites this paper
• Unlocking the power of sugar: carbohydrate ligands as key players in nanotherapeutic-assisted targeted cancer therapy.

  2024cites this paper
• αvβ3 integrin-targeted pH-responsive dendritic nanocarriers for enhanced anti-tumor efficacy of docetaxel against breast cancer

  2024cites this paper
• Targeting Breast Cancer with N-Acetyl-D-Glucosamine: Integrating Machine Learning and Cellular Assays for Promising Results.

  2024cites this paper
• Aptamer tethered bio-responsive mesoporous silica nanoparticles for efficient targeted delivery of paclitaxel to treat ovarian cancer cells.

  2023cites this paper
• A review of the preparation, derivatization and functions of glucosamine and N-acetyl-glucosamine from chitin

  2023cites this paper
• Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment

  2023cites this paper
• Research progress of nanomaterial drug delivery in tumor targeted therapy

  2023cites this paper
• Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery

  2023cites this paper
• GLUT1 transporter-facilitated solid lipid nanoparticles loaded with anti-cancer therapeutics for ovarian cancer targeting.

  2023cites this paper
• Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles

  2023cites this paper
• Tuning Mesoporous Silica Nanoparticles in Novel Avenues of Cancer Therapy.

  2022cites this paper
• Recent Advances in Nanotechnology-Based Targeted Therapeutics for Breast Cancer Management.

  2022cites this paper
• Eliminating host-guest incompatibility via enzyme mining enables the high-temperature production of N-acetylglucosamine

  2022cites this paper
• Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress

  2022influential citation
• Chemosensitivity assessments of curdlan-doped smart nanocomposites containing erlotinib HCl.

  2021cites this paper
• Mesoporous Silica Nanoparticles

  2021cites this paper
• Glucosamine-conjugated graphene quantum dots as versatile and pH-sensitive nanocarriers for enhanced delivery of curcumin targeting to breast cancer.

  2021cites this paper
• Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy.

  2021cites this paper
• Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery.

  2021cites this paper
• Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells

  2021cites this paper
• siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells

  2021cites this paper
• Erlotinib-loaded carboxymethyl temarind gum semi-interpenetrating nanocomposites.

  2020cites this paper
• Spray drying as an efficient route for synthesis of silica nanoparticles-sodium alginate biohybrid drug carrier of doxorubicin.

  2020cites this paper
• Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies

  2020cites this paper
• Folic acid conjugated nanocarriers for efficient targetability and promising anticancer efficacy for treatment of breast cancer: A review of recent updates.

  2020cites this paper
• Non-nuke HIV-1 inhibitor shuttled by mesoporous silica nanoparticles effectively slows down HIV-1 replication in infected human cells.

  2020cites this paper
• Carboxymethyl fenugreek galactomannan-g-poly(N-isopropylacrylamide-co-N,N'-methylene-bis-acrylamide)-clay based pH/temperature-responsive nanocomposites as drug-carriers.

  2020cites this paper
• Smart nanocarriers in glucose transporters-targeted delivery of anticancer drugs

  2020cites this paper
• Recent advances in folic acid engineered nanocarriers for treatment of breast cancer

  2020cites this paper
• Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).

  2020cites this paper
• A NAG-Guided Nano-Delivery System for Redox- and pH-Triggered Intracellularly Sequential Drug Release in Cancer Cells

  2020cites this paper
• Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy

  2020cites this paper
• cRGD functionalised nanocarriers for targeted delivery of bioactives

  2019cites this paper
• A robust pH-sensitive unimolecular dendritic nanocarrier that enables targeted anti-cancer drug delivery via GLUT transporters.

  2018cites this paper
• Smart Mesoporous Nanomaterials With Improved Therapeutic Applications: Therapeutic Application of MSN

  2018cites this paper
• Fabrication of poly(ethylene glycol)‐coated mesoporous nanocomposite ZnO@Fe2O3 for methotrexate delivery: An integrated nanoplatform for dual‐mode cancer therapy

  2018cites this paper
• Mesoporous silica nanoparticles as cutting‐edge theranostics: Advancement from merely a carrier to tailor‐made smart delivery platform

  2018cites this paper
• Metabolic engineering of carbon overflow metabolism of Bacillus subtilis for improved N-acetyl-glucosamine production.

  2018cites this paper
• Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells

  2018cites this paper
• Synthesis and Characterization of Folate Conjugated Boron Nitride Nanocarriers for Targeted Drug Delivery

  2017cites this paper
• The Warburg effect and glucose-derived cancer theranostics.

  2017cites this paper